Acquired by Cayman Matreya LLC was acquired by Cayman Chemical in June 2019, indicating potential alignment with Cayman’s lipid biochemistry focus and access to established distribution channels and customer relationships in lipid analytics.

Lipid Expertise Specialization in synthesis, extraction, and purification of natural lipid products suggests opportunities to cross-sell lipid standards, analytical reagents, and contract lipidomics services to existing Matreya/Cayman customers.

Small Scale Very small operation (0-1 employees) with revenue under one million, signaling high interest in scalable collaborations, outsourcing partnerships, and cost-effective, contract-based engagements rather than full-time sales cycles.

Biotech Stack Tech footprint includes AWS, Azure, S3, and ASP.NET with modern web technologies, offering potential for selling cloud-based data management, lab informatics, or analytics solutions integrated with lipidomics workflows.

Competitive Positioning Similar company landscape includes large players like Cayman Chemical, MP Biomedicals, and Thermo Fisher, suggesting a sales approach focused on niche lipidics, entry-level collaborations, or service-based offerings to complement larger suppliers.